Mettler-Toledo International (NYSE:MTD – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 46.300-46.950 for the period, compared to the consensus EPS estimate of 46.510. The company issued revenue guidance of $4.2 billion-$4.2 billion, compared to the consensus revenue estimate of $4.2 billion. Mettler-Toledo International also updated its Q2 2026 guidance to 10.700-10.850 EPS.
Analyst Ratings Changes
Several equities analysts recently issued reports on MTD shares. Wall Street Zen raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Morgan Stanley lowered their price target on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 10th. Jefferies Financial Group raised Mettler-Toledo International from a “hold” rating to a “buy” rating and increased their price target for the company from $1,400.00 to $1,450.00 in a report on Friday, March 20th. Finally, Barclays lowered their price target on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Seven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International has an average rating of “Moderate Buy” and a consensus target price of $1,459.58.
View Our Latest Stock Report on Mettler-Toledo International
Mettler-Toledo International Stock Down 0.5%
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. The firm had revenue of $947.13 million during the quarter, compared to the consensus estimate of $943.14 million. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter last year, the firm earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. Analysts anticipate that Mettler-Toledo International will post 46.51 earnings per share for the current year.
Insider Transactions at Mettler-Toledo International
In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the completion of the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,456,714.56. This trade represents a 13.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.71% of the stock is currently owned by insiders.
Institutional Trading of Mettler-Toledo International
Several institutional investors have recently added to or reduced their stakes in the company. Benjamin Edwards Inc. raised its stake in shares of Mettler-Toledo International by 4.8% during the second quarter. Benjamin Edwards Inc. now owns 218 shares of the medical instruments supplier’s stock valued at $256,000 after acquiring an additional 10 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Mettler-Toledo International by 4.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 256 shares of the medical instruments supplier’s stock valued at $362,000 after acquiring an additional 11 shares in the last quarter. Meeder Advisory Services Inc. raised its stake in shares of Mettler-Toledo International by 4.3% during the fourth quarter. Meeder Advisory Services Inc. now owns 290 shares of the medical instruments supplier’s stock valued at $404,000 after acquiring an additional 12 shares in the last quarter. Parallel Advisors LLC raised its stake in shares of Mettler-Toledo International by 5.6% during the third quarter. Parallel Advisors LLC now owns 300 shares of the medical instruments supplier’s stock valued at $368,000 after acquiring an additional 16 shares in the last quarter. Finally, Modern Wealth Management LLC raised its stake in shares of Mettler-Toledo International by 6.5% during the second quarter. Modern Wealth Management LLC now owns 293 shares of the medical instruments supplier’s stock valued at $344,000 after acquiring an additional 18 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Featured Articles
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
